Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
Exclusive content, detailed data sets, and best-in-class trade insights to rewrite your portfolio for tomorrow.
Try it NowFebruary 06, 2026 — 3:45 PM - 4:15 PM ET
Nasdaq MarketSite, 4 Times Square, New York
AgomAb Therapeutics NV (Nasdaq: AGMB), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Tim Knotnerus, CEO rings the Closing Bell.
